IP Library Granted Patent US 8,738,398
Granted Patent B1
US 8,738,398 · App. 13/284,423 · Granted May 27, 2014

Methods and apparatus for improving healthcare

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,738,398
App. No.
13/284,423
Granted
May 27, 2014
Kind
B1
Abstract

The present disclosure provides methods and apparatus for obtaining and using outcome information associated with a prescription drug. In an embodiment, doctors and patients are registered in a central prescription distribution system. Preferably, drugs prescribed using the central prescription distribution system are only available through the system and are shipped from one or more distribution hubs directly to the patient. Outcome data is collected from the patients in the system and used in a variety of ways.

Claims (36)

1. A computer-implemented method of prescribing a prescription drug indicated for use in treating an indicated medical condition and for monitoring and tracking patient response to use of said prescription drug by a patient diagnosed with said indicated medical condition, said method comprising the steps of:

(a) electronically receiving and storing, in a database, data concerning an indicated medical condition;

(b) electronically receiving and storing, in a database, data concerning a prescription drug indicated for use treating said indicated medical condition;

(c) electronically receiving and storing, in a database, one or more outcome data types pre-selected by one or more medical professionals; said one or more outcome data types being associated in said database with said indicated medical condition and said prescription drug; said one or more outcome data types correlating the effect of use of said prescription drug by a patient diagnosed with said indicated medical condition to the treatment of said indicated medical condition in said patient;

(d) electronically receiving and storing, in a database, data concerning an outcome information monitoring device; said outcome information monitoring device being capable of obtaining patient outcome information corresponding to said one or more outcome data types;

(e) electronically receiving doctor registration data from a doctor, and storing said doctor registration data in a database; said doctor registration data including information concerning said doctor;

(f) electronically receiving patient registration data from at least one of said doctor and said patient, and storing said patient registration data in a database; said patient registration data including information concerning said patient;

(g) electronically receiving prescription data from said doctor, and storing said prescription data in a database; said prescription data including information concerning said patient, said patient's indicated medical condition, and said prescription drug indicated for use in treating said patient's indicated medical condition;

(h) electronically receiving payer data received from at least one of said doctor, said patient and a payer, and storing said payer data in a database; said payer data including information concerning a payer, said patient, and said prescription drug;

(i) electronically verifying that doctor registration data is stored in said database of step (e) for said doctor providing said prescription data of step (g);

(j) if said doctor registration data is verified in step (i), causing said prescription drug to be provided to said patient as indicated by said patient's patient registration data stored in said database of step (f); said prescription drug being provided directly to said patient from a single prescription drug fulfillment source one or a plurality of times, as indicated by said prescription data stored in said database of step (g);

(k) causing an outcome information monitoring device to be provided to said patient based on said outcome information monitoring device data stored in said database of step (d);

(l) electronically receiving fulfillment data, and storing said fulfillment data in a database; said fulfillment data including information concerning fulfillment of said prescription drug by said single prescription drug fulfillment source of step (j); and

(m) electronically receiving, from said patient, patient outcome information corresponding to said one or more outcome data types and obtained by said outcome information monitoring device provided to said patient in step (k), and storing said patient outcome information in a database;

said steps (a)-(m) being implemented in a computer system comprising one or more processors configured to execute one or more computer programs; and

said fulfillment data and said patient outcome information being available to at least one of said doctor, said patient and said payer through one or more electronic interfaces of said computer system to monitor and track patient compliance to said prescription data and patient response to said prescription drug, and to correlate said fulfillment data to said patient response to said prescription drug, and wherein said computer system compares said fulfillment data of step (l) to said prescription data of step (g) to determine patient compliance, and electronically notifies at least one of said doctor, said patient and said payer if said patient is not compliant.

2. A computer-implemented method according to claim 1 , further comprising the steps of electronically storing in said computer system, in a database, data concerning a second prescription drug indicated for use in treating said patient's indicated medical condition, said second prescription drug being different from said prescription drug indicated by said prescription data; determining in said computer system if said second prescription drug is indicated for use by said patient on the basis of said patient outcome information; and electronically communicating said determination to said doctor.

3. A computer-implemented method according to claim 1 , wherein said step of electronically receiving said prescription data from said doctor occurs before said step of electronically receiving said patient registration information; occurs after said step of receiving said patient registration information; or occurs at the same time as said step of receiving said patient registration information.

4. A computer-implemented method according to claim 1 , further comprising: the steps of electronically receiving a query in said computer system; and electronically delivering, in said computer system, a report based on said patient outcome information in response to said query.

5. A computer-implemented method according to claim 4 , wherein said query comes from at least one of said doctor, said payer, and said patient.

6. A computer-implemented method according to claim 4 , wherein said report includes a comparison of said second prescription drug to said prescription drug indicated by said prescription data.

7. A computer-implemented method according to claim 1 , wherein said one or more outcome data types are selected from the group consisting of: change in blood pressure; occurrence of cardiovascular events; change in at least one of blood sugar and HBA1c; change in total cholesterol; change in worsening of condition; change in joint function; change in tumor response rate; change in at least one of exercise persistence and shortness of breath; change in skin condition; change in patient observation of pain; and change in quality of life score.

8. A computer-implemented method according to claim 1 , wherein said indicated medical condition is selected from the group consisting of: hypertension; type 2 diabetes; high cholesterol; Alzheimer's disease; rheumatoid arthritis; breast cancer; chronic obstructive pulmonary disorder (COPD); atopic dermatitis; and pain.

9. A computer-implemented method according to claim 1 , wherein said prescription drug is a drug selected from the group consisting of: ACE inhibitors; DPP-4 inhibitors; statins; cholinesterase inhibitors; TNF-alpha inhibitors; taxanes; beta-2 agonists; corticosteroids; and NSAIDS.

10. A computer-implemented method according to claim 1 , wherein said outcome information monitoring device is selected from the group consisting of: a blood pressure monitor; a blood glucose monitor; and a cholesterol test kit.

11. A computer-implemented method according to claim 1 , wherein said computer system comprises a doctor client device, a patient client device, a payer client device and one or more database servers, each of which is different from and in network communication with each other; said prescription data being electronically received from said doctor client device and said patient outcome information being electronically received from said patient client device; and each of said databases being stored on said one or more database servers.

12. A computer-implemented method according to claim 11 , wherein said indicated medical condition is hypertension; said prescription drug indicated for use in treating said hypertension is an ACE inhibitor; said one or more outcome data types associated with said hypertension is at least one of change in blood pressure and occurrence of cardiovascular events; and said outcome information monitoring device is a blood pressure monitor.

13. A computer-implemented method according to claim 11 , wherein said indicated medical condition is Type 2 diabetes; said prescription drug indicated for use in treating said Type 2 diabetes is a DPP-4 inhibitor; said one or more outcome data types associated with said Type 2 diabetes is change in at least one of blood sugar and HBA1c, and occurrence of cardiovascular events; and said outcome information monitoring device is a blood glucose monitor.

14. A computer-implemented method according to claim 11 , wherein said indicated medical condition is high cholesterol; said prescription drug indicated for use in treating said high cholesterol is a statin; said one or more outcome data types associated with said high cholesterol is at least one of change in total cholesterol and occurrence of cardiovascular events; and said outcome information monitoring device is a cholesterol test kit.

15. A computer-implemented method according to claim 2 , wherein the dosage of said second prescription drug is different from the dosage of said prescription drug indicated by said prescription data.

16. A computer-implemented according to claim 2 , wherein the active ingredient of said second prescription drug is different from the active ingredient of said prescription drug indicated by said prescription data.

17. A computer-implemented method according to claim 2 , wherein the active ingredient of said second prescription drug is the same as the active ingredient of said prescription drug indicated by said prescription data; said active ingredient of said second prescription drug being at a different dosage level that said same active ingredient of said prescription drug indicated by said prescription data.

18. A computer-implemented method according to claim 2 , wherein the frequency of consumption of said second prescription drug is different from the frequency of consumption of said prescription drug indicated by said prescription data.

19. A computer-implemented method according to claim 2 , wherein said second prescription drug and said prescription drug indicated by said prescription data are taken by said patient at different times of the day.

20. A computer-implemented method according to claim 2 , wherein said second prescription drug and said prescription drug indicated by said prescription data are administered to said patient together as a fixed dose combination or separately as a combination monotherapy.

21. A computer-implemented method according to claim 2 , further comprising the step of electronically comparing, in said computer system, the efficacy of said prescription drug indicated by said prescription data administered in the absence of said second prescription drug, to the efficacy of said prescription drug indicated by said prescription data administered in combination with said second prescription drug.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: SILICON VALLEY BANK
To: XOMA TECHNOLOGY LTD.
Reel/Frame 073790/0484 →
SECURITY INTEREST Recorded May 9, 2018
From: XOMA TECHNOLOGY LTD.
To: SILICON VALLEY BANK
Reel/Frame 046115/0459 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE NAME OF ASSIGNOR JEFFREY D. FELDSTEIN ON THE COVER SHEET OF THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 030869 FRAME 0846. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT SPELLING IS SET FORTH ON PAGE 1 OF THE ASSIGNMENT. Recorded Jul 30, 2013
From: EMERSON, ERIK; FELDSTEIN, JEFFREY D.
To: SYMPIMED PHARMACEUTICALS LLC
Reel/Frame 031032/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: EMERSON, ERIK; FELDSTEIN, JEFFRETY D.
To: SYMPLMED PHARMACEUTICALS LLC
Reel/Frame 030869/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: XOMA COMMERCIAL LLC
To: EMERSON, ERIK; FELDSTEIN, JEFFREY D.
Reel/Frame 030869/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2013
From: XOMA COMMERCIAL LLC
To: EMERSON, ERIK; FELDSTEIN, JEFFREY D.
Reel/Frame 030790/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2012
From: XOMA TECHNOLOGY LTD.
To: XOMA COMMERCIAL LLC
Reel/Frame 029445/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2012
From: EMERSON, ERIK
To: XOMA TECHNOLOGY LTD.
Reel/Frame 027618/0268 →